A startup seeking potential new drugs within blooms of algae has raised $500,000 and is moving its headquarters to San Diego to take part in a business accelerator run by pharmaceutical giant Johnson & Johnson.
“We actually expect to continue to expand in Ohio,” founder and interim CEO Ross Youngs said, repeating his pledge made when he hinted at an upcoming move last month.
Dublin-based Biosortia Pharmaceuticals Inc. is keeping its operations facility on the west side of Columbus, where it maintains and improves the field equipment for harvesting algae.
